A Phase II/III Clinical Study on Inhibitory Effects of E0167 on Recurrence of Hepatocellular Carcinoma
Status:
Terminated
Trial end date:
2007-03-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine the superiority of inhibitory effects and safety of
Menatetrenone (E0167) on recurrence in patients with hepatocellular carcinoma.